Overview

The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

The effect of vildagliptin based treatment versus sulfonylurea based treatment on glycemic variability, oxidative stress, and endothelial function in patients with type 2 diabetes.

Phase:

Phase 4

Details

Lead Sponsor:

Samsung Medical Center

Collaborator:

Novartis

Treatments:

Glimepiride
Metformin
Vildagliptin